Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'MultiHance' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'MultiHance' found in 1 term [] and 8 definitions []
1 - 5 (of 9)     next
Result Pages : [1]  [2]
Searchterm 'MultiHance' was also found in the following service: 
spacer
News  (2)  
 
MultiHance®InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
MultiHance® is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (MRI) of the liver and central nervous system. MultiHance® is a small molecular weight chelate, which tightly binds the Gd atom. The substance is excreted partly by the kidneys, partly by the biliary system, which is especially unique.
MultiHance® is indicated, for the detection of focal liver lesions in patients with known or suspected primary liver cancer (e.g. hepatocellular carcinoma) or metastatic disease.
MultiHance® is also indicated in brain MRI and spine MRI where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced MRI.
Gd-BOPTA-enhanced MRA can provide superior vascular signal intensity and SNR, as compared with Gd-DTPA, due to its higher relaxivity, even at lower doses.
1 ml of solution MultiHance® contains: (0.5M) gadobenate dimeglumine 529 mg = gadobenic acid 334 mg + meglumine 195 mg. Viscosity at 37°C: 5.3 mPa

WARNING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m2), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.
Drug Information and Specification
NAME OF COMPOUND
Gadobenate dimeglumine, Gd-BOPTA, E7155
DEVELOPER
CENTRAL MOIETY
Gd2+
CONTRAST EFFECT
T1, predominantly positive enhancement
r1=9.7, r2=12.5, B0=0.5 T
PHARMACOKINETIC
Extracellular, hepatobiliary
1970 mosm/kg
CONCENTRATION
334 mg/ml
DOSAGE
0.05 mmol/kg for Liver MRI
0.1 mmol/kg for CNS MRI
PREPARATION
Solution for injection
INDICATION
CNS, Liver MRI
DEVELOPMENT STAGE
For sale
DISTRIBUTOR
See below
PRESENTATION
Vials of 5, 10, 15 and 20 mL, 50 and 100 mL Multipacks (Pharmacy Bulk Package)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT
STAGE
DISTRIBUTOR
EU
MultiHance®
for sale
USA
MultiHance®
for sale
Australia
MultiHance®
for sale
spacer
 
• Share the entry 'MultiHance®':  Facebook  Twitter  LinkedIn  

• View the NEWS results for 'MultiHance®' (1).Open this link in a new window.
 
Further Reading:
  Basics:
Important Drug Warning for Gadolinium-Based Contrast Agents
Wednesday, 12 September 2007   by www.ismrm.org    
MultiHance Package Insert(.pdf)
   by www.fda.gov    
  News & More:
FDA Expands Pediatric Age Range for MultiHance Contrast Agent
Tuesday, 30 January 2018   by www.empr.com    
MAGNETIC RESONANCE IMAGING OF FOCAL LIVER LESIONS(.pdf)
2002
BRACCO DIAGNOSTICS' MULTIHANCE EARNS FDA APPROVAL
Wednesday, 24 November 2004   by salesandmarketingnetwork.com    
MRI Resources 
Safety Training - Education - MR Guided Interventions - Mobile MRI - Software - MRI Technician and Technologist Schools
 
B-19036InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Short name: B-19036, central moiety: Gd+
B19036/7 compared with E-7155, Gd-BOPTA, Gd-BOPTA/Dimeg are synonyms for the contrast agent MultiHance®, marketed by Bracco Diagnostics Inc, Milan, Italy. B-19036 is a gadolinium chelate. See also the contrast agent info sheet about classifications, characteristics, etc.
spacer
 
Further Reading:
  News & More:
FDA Expands Pediatric Age Range for MultiHance Contrast Agent
Tuesday, 30 January 2018   by www.empr.com    
MRI Resources 
General - Chemistry - MRCP - Liver Imaging - Services and Supplies - DICOM
 
Bracco Diagnostics, Inc.MRI Resource Directory:
 - Manufacturers -
 
www.bdi.bracco.com The company is a member of the Bracco Group, a highly innovative healthcare group and world leader in global integrated solutions for the diagnostic medical imaging field. The Bracco Group is headquartered in Milan, Italy. Its North American operations consist of Bracco Diagnostics and Bracco Research USA, both located in Princeton, New Jersey. Bracco Diagnostics is one of the fastest growing developers and marketers of diagnostic pharmaceuticals in North America, with products for various imaging applications, including Isovue® (iopamidol - X-ray contrast agent), ProHance® (gadoteridol - MRI contrast agent), SonoVue® (ultrasound contrast agent) and nuclear medicine products.
Gadoteridol has been available in Europe and the USA for several years. Holder of the Marketing Authorization: Bracco International B.V. - Strawinskylaan 3051 - 1077 ZX Amsterdam The Netherlands. (Contact: Kirk Deeter, Phone: +NL-303-838-8708)

MRI Contrast Agents:
•
•
•
•
Contact Information
Please see Bracco Diagnostics, Inc.'s
spacer

• View the DATABASE results for 'Bracco Diagnostics, Inc.' (2).Open this link in a new window

 
Further Reading:
  News & More:
FDA Expands Pediatric Age Range for MultiHance Contrast Agent
Tuesday, 30 January 2018   by www.empr.com    
BRACCO DIAGNOSTICS' MULTIHANCE EARNS FDA APPROVAL
Wednesday, 24 November 2004   by salesandmarketingnetwork.com    
Searchterm 'MultiHance' was also found in the following service: 
spacer
News  (2)  
 
Bracco-Eisai Co., Ltd.MRI Resource Directory:
 - Manufacturers -
 
Eisai Co., Ltd. (Tokyo, Japan, President: Haruo Naito) and Bracco-Eisai Co., Ltd. (Tokyo, Japan, President: Toshio Matsumoto) decided to withdraw the new drug application (NDA) of E7155 (gadobenate meglumine), since new indications are emerging for the product and additional clinical data was necessary to complete the targeting product competitive risk/benefit profile. The product is currently marketed in other countries, and both companies are discussing a future development plan in Japan.

MRI Contrast Agents:
Contact Information
MAIL
Bracco Eisai Co., Ltd.
2-6, Kohinata 4-chome, Bunkyo-ku, Tokyo, 112-0006
PHONE
+03-3817-3939
spacer

• View the DATABASE results for 'Bracco-Eisai Co., Ltd.' (2).Open this link in a new window

MRI Resources 
Musculoskeletal and Joint MRI - Pregnancy - Stent - Online Books - Diffusion Weighted Imaging - MR Guided Interventions
 
Gadobenate DimeglumineInfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.
 
Short name: Gd-BOPTA, generic name: Gadobenate dimeglumine
A paramagnetic MRI contrast agent (small molecular weight Gd-chelate) with 0.5 and 0.25 molar concentration.
The albumin-mediated relaxation enhancement may result in advantages for Gd-BOPTA over Gd-DTPA and other gadolinium agents in poorly vascularized, small, or lesions with low enhancement and in tumors with high concentrations of albumin. The substance is excreted partly by the kidneys (75-90%), partly by the biliary system (10-25%). The uptake in the liver is about 5% in humans. It is bolus injectable.

See Contrast Agents and MultiHance®.
spacer

• View the DATABASE results for 'Gadobenate Dimeglumine' (5).Open this link in a new window


• View the NEWS results for 'Gadobenate Dimeglumine' (1).Open this link in a new window.
 
Further Reading:
  Basics:
MultiHance Package Insert(.pdf)
   by www.fda.gov    
MRI Resources 
MRI Accidents - PACS - - Fluorescence - Cochlear Implant - Movies
 
     1 - 5 (of 9)     next
Result Pages : [1]  [2]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Next big thing in MRI will be :
AI 
remote operator 
personalized protocols 
helium-free 
molecular MRI 
portable MRI 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 28 March 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]